skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

131 studies were found about ( Epzicom OR abacavir AND lamivudine )

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00740064

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment

Condition: HIV Infections

NCT ID: NCT00544128

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Condition: HIV Infection

NCT ID: NCT00244712

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00440947

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00046176

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

Condition: HIV Infection

NCT ID: NCT01982396

Safety and Efficacy Study of Switching From Epzicom to Truvada

Condition: HIV Infection

NCT ID: NCT00724711

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01059422

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00044577

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00085943

Pharmacokinetic Study Of EPZICOM Tablet

Condition: HIV Infection

NCT ID: NCT00337922

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Condition: HIV Infections

NCT ID: NCT00005017

Once-Daily Drug Regimen for HIV-Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001968

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002389

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00004585

Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD)

Condition: HIV-1 Infection

NCT ID: NCT02067767

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00006617

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Condition: HIV Infections

NCT ID: NCT00002391

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01102972

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

Condition: Human Immunodeficiency Virus

NCT ID: NCT02028676

Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)

Condition: HIV; Tuberculosis

NCT ID: NCT00851630

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Condition: HIV Infections

NCT ID: NCT00004981

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Condition: HIV Infections

NCT ID: NCT00002199

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00011895

Raltegravir Switch for Toxicity or Adverse Events

Condition: HIV/AIDS; Antiretroviral Therapy; HIV Infections

NCT ID: NCT00958100

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01910402

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

Condition: HIV Infections

NCT ID: NCT00192634

A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)

Condition: HIV Infection

NCT ID: NCT01900106

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00009061

Artery Elasticity After Switch From Epzicom to Truvada

Condition: HIV Infections

NCT ID: NCT00998582

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00549198

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005106

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01263015

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Condition: HIV Infections

NCT ID: NCT00118898

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Condition: HIV Infection

NCT ID: NCT00038506

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Condition: HIV Infection

NCT ID: NCT00280969

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

Condition: HIV Infections

NCT ID: NCT00314626

Abacavir and Lamivudine PK in Children

Condition: HIV

NCT ID: NCT01656122

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

Condition: HIV Infection

NCT ID: NCT00094367

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Condition: HIV Infection

NCT ID: NCT00053638

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Condition: HIV-1 Infection

NCT ID: NCT00915655

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Condition: HIV Infections

NCT ID: NCT00002409

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00000940

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01641809

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004855

A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Condition: HIV Infections

NCT ID: NCT00002423

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

Condition: HIV-1

NCT ID: NCT00772902

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Condition: HIV Infections

NCT ID: NCT00318123

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002245

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

Condition: HIV Infections

NCT ID: NCT00002233

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00008554

A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02105987

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

Condition: HIV Infections

NCT ID: NCT00338390

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

Condition: HiV1- Positive

NCT ID: NCT01608269

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231555

Evaluation of the Bioequivalence of a Combined Formulated Tablet

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01622790

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01366547

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents

Condition: Human Immuno Deficiency (HIV) Infections

NCT ID: NCT00799864

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months

Condition: HIV Infection

NCT ID: NCT01973439

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Condition: HIV

NCT ID: NCT00960622

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00002183

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000872

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Condition: HIV Infections

NCT ID: NCT00000885

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Condition: HIV Infections

NCT ID: NCT00013520

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00727597

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Condition: HIV Infections

NCT ID: NCT00006578

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT00000865

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

Condition: HIV

NCT ID: NCT00335192

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002217

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Condition: Fracture; Infection, Human Immunodeficiency Virus

NCT ID: NCT01077557

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01499199

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00002216

Blood Levels of Abacavir in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00087945

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00951015

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00450580

Increasing HAART-Induced Immune Restoration With Cyclosporine

Condition: HIV Infections

NCT ID: NCT00031070

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Condition: HIV Infections

NCT ID: NCT00214890

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001119

FREE Study: Efficacy and Toxicity of Trizivir

Condition: HIV Infections

NCT ID: NCT00405925

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00021463

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001086

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02075593

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00078247

HIV Treatment and CVD Events

Condition: HIV Infection; Cardiovascular Disease; Infection, Human Immunodeficiency Virus; Acute Myocardial Infarction

NCT ID: NCT01054638

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00000922

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

Condition: HIV Infections

NCT ID: NCT00615810

Sex, Aging and Antiretroviral Pharmacokinetics

Condition: HIV Infections

NCT ID: NCT00666055

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00005018

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01449929

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00820118

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01363011

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00876733

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Condition: HIV Infections

NCT ID: NCT00043888

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

Condition: HIV Infections

NCT ID: NCT00312169

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

Condition: HIV; Impaired Cognition

NCT ID: NCT01367236

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01227824

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Condition: Healthy Volunteers

NCT ID: NCT01220232

Drug Exposure Registry for GSK2248761, an Investigational NNRTI

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01458132

Telaprevir Open-Label Study in Co-Infected Patients

Condition: Hepatitis C, Chronic

NCT ID: NCT01500616

Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts

Condition: HIV-1 Infection; Immunosuppression-related Infectious Disease

NCT ID: NCT01928407

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Condition: Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus

NCT ID: NCT01448707

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733